Tapewire

NYSE · USD

NVST

Envista Holdings Corp

Export transactions ↓
Tapewire entity
4007
SEC CIK
0001757073
Parsed reports
315

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Tax withholdingCommon Stock 3,813 $20.66 $78,776.58
Disclosure

SEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,907

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs").

Read SEC document
February 01, 2025 Filed Feb 4, 2025 21:52 UTC
Befidi RobertPresident, Diagnostics
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 1,151 $20.52 $23,618.52
Disclosure

SEC source: 0001757073-25-000004 · wk-form4_1738705954.xml · derivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,151

Underlying: Common Stock · 1,151 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2025 Filed Feb 4, 2025 16:52 UTC
Kaabi Faez CChief Accounting Officer
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 689 $20.52 $14,138.28
Disclosure

SEC source: 0001757073-25-000002 · wk-form4_1738705932.xml · derivative · entry 1

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,854

Underlying: Common Stock · 689 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2025 Filed Feb 4, 2025 16:52 UTC
Nance Mark EGeneral Counsel
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 965 $20.52 Strike: $0.00 $19,801.80
Disclosure

SEC source: 0001757073-25-000003 · wk-form4_1738705944.xml · derivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,581

Underlying: Common Stock · 965 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2025 Filed Feb 4, 2025 21:52 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantExecutive Deferred Incentive Program - Envista Stock Fund · Derivative 3,152 $20.52 Strike: $0.00 $64,679.04
Disclosure

SEC source: 0001757073-25-000001 · wk-form4_1738705921.xml · derivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,438

Underlying: Common Stock · 3,152 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: All contributions to the reporting person's EDIP Stock Fund are 80% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock.

F2 · derivative.expiration_date: All contributions to the reporting person's EDIP Stock Fund are 80% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "EDIP Stock Fund") in the reporting person's Executive Deferred Incentive Program (the "EDIP") account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last trading day of the prior year. The price shown in Table II, Column 8 is the closing price per share of Envista common stock as reported on the NYSE on the date the contribution was actually made (or the closing price for the immediately preceding business day, if such date is not a business day).

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:10 UTC
Keel Paul ADirector · Chief Executive Officer
Tax withholdingCommon Stock 53,996 $20.94 $1,130,676.24
Disclosure

SEC source: 0001757073-24-000079 · wk-form4_1730754641.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,609

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU")

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:25 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Tax withholdingCommon Stock 812 $19.00 $15,428.00
Disclosure

SEC source: 0001757073-24-000076 · wk-form4_1726777533.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,720

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
August 25, 2024 Filed Aug 27, 2024 21:32 UTC
Befidi RobertPresident, Diagnostics
GrantPerformance Option · Derivative 70,400 $0.00 Strike: $18.70 $0.00
Disclosure

SEC source: 0001757073-24-000071 · wk-form4_1724794212.xml · derivative · entry 2

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,400

Underlying: Common Stock · 70,400 shares

Expires 2034-08-25

F2 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days.

Read SEC document
August 25, 2024 Filed Aug 27, 2024 21:32 UTC
Befidi RobertPresident, Diagnostics
Tax withholdingCommon Stock 3,454 $18.70 $64,589.80
Disclosure

SEC source: 0001757073-24-000071 · wk-form4_1724794212.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,791

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
August 25, 2024 Filed Aug 27, 2024 21:24 UTC
Hammes Eric D.Chief Financial Officer
GrantCommon Stock 64,175 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000070 · wk-form4_1724793810.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,707

F1 · shares: Consists of Restricted Stock Units (" RSUs") that will vest as to 21,391 shares of Issuer's common stock on August 25, 2025 and as to 21,392 shares of Issuer's common stock on each of August 25, 2026 and 2027, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
August 25, 2024 Filed Aug 27, 2024 21:40 UTC
Keel Paul ADirector · Chief Executive Officer
GrantPerformance Option · Derivative 485,680 $0.00 Strike: $18.70 $0.00
Disclosure

SEC source: 0001757073-24-000073 · wk-form4_1724794822.xml · derivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 485,680

Underlying: Common Stock · 485,680 shares

Expires 2034-08-25

F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days.

Read SEC document
August 25, 2024 Filed Aug 27, 2024 17:43 UTC
Nance Mark EGeneral Counsel
GrantPerformance Option · Derivative 95,240 $0.00 Strike: $18.70 $0.00
Disclosure

SEC source: 0001757073-24-000074 · wk-form4_1724794990.xml · derivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,240

Underlying: Common Stock · 95,240 shares

Expires 2034-08-25

F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days.

Read SEC document
August 25, 2024 Filed Aug 27, 2024 21:37 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantPerformance Option · Derivative 57,980 $0.00 Strike: $18.70 $0.00
Disclosure

SEC source: 0001757073-24-000072 · wk-form4_1724794638.xml · derivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,980

Underlying: Common Stock · 57,980 shares

Expires 2034-08-25

F1 · derivative.exercise_date: Consists of Performance Options that have a 3-year cliff vest, subject to performance stock price attainment of 133% of the grant date price for 20 consecutive trading days.

Read SEC document
August 13, 2024 Filed Aug 14, 2024 20:40 UTC
Keel Paul ADirector · Chief Executive Officer
PurchaseCommon Stock 30,000 $16.87 $506,100.00
Disclosure

SEC source: 0001757073-24-000069 · wk-form4_1723668014.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,605

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.37 to $17.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 22:01 UTC
Hammes Eric D.Chief Financial Officer
PurchaseCommon Stock 24,532 $16.33 $400,607.56
Disclosure

SEC source: 0001757073-24-000068 · wk-form4_1723586463.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,532

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.26 to $16.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 16:12 UTC
Nance Mark EGeneral Counsel
Tax withholdingCommon Stock 491 $15.94 $7,826.54
Disclosure

SEC source: 0001757073-24-000064 · wk-form4_1721247150.xml · nonDerivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,481

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:32 UTC
Keller StephenPrincipal Financial Officer
GrantCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000062 · wk-form4_1719520349.xml · nonDerivative · entry 1

Keller Stephen · CIK 0001993880 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,803

F1 · balance_after: Consists of Restricted Stock Units ("RSU") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
May 25, 2024 Filed May 29, 2024 20:23 UTC
Keel Paul ADirector · Chief Executive Officer
GrantPerformance Share Unit · Derivative 205,265 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 5

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,265

Underlying: Common Stock · 205,265 shares

Expires not disclosed

F5 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F5 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F5 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period ending on December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
May 25, 2024 Filed May 29, 2024 20:23 UTC
Keel Paul ADirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 164,560 $0.00 Strike: $18.25 $0.00
Disclosure

SEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 4

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,560

Underlying: Common Stock · 164,560 shares

Expires 2034-05-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
May 25, 2024 Filed May 29, 2024 20:23 UTC
Keel Paul ADirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 696,210 $0.00 Strike: $18.25 $0.00
Disclosure

SEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · derivative · entry 3

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 696,210

Underlying: Common Stock · 696,210 shares

Expires 2034-05-25

F3 · derivative.exercise_date: This Option will vest as to 232,070 shares of Issuer common stock on each of November 1, 2024, 2025 and 2026, subject to continued service through each such date.

Read SEC document
May 25, 2024 Filed May 29, 2024 20:23 UTC
Keel Paul ADirector · Chief Executive Officer
GrantCommon Stock 301,370 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · nonDerivative · entry 2

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 372,605

F2 · balance_after: Consists of RSUs that will vest as to 100,456 shares of Issuer common stock on November 1, 2024, and as to 100,457 shares of Issuers common stock on each of November 1, 2025 and 2026, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock

Read SEC document
May 25, 2024 Filed May 29, 2024 20:23 UTC
Keel Paul ADirector · Chief Executive Officer
GrantCommon Stock 71,235 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000057 · wk-form4_1717014217.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,235

F1 · balance_after: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
May 25, 2024 Filed May 29, 2024 20:24 UTC
Conley EricSVP, Orthodontics
Tax withholdingCommon Stock 642 $18.25 $11,716.50
Disclosure

SEC source: 0001757073-24-000058 · wk-form4_1717014231.xml · nonDerivative · entry 1

Conley Eric · CIK 0001966479 · SVP, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,223

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
May 21, 2024 Filed May 23, 2024 20:32 UTC
Jain VivekDirector
GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000050 · wk-form4_1716496341.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,165

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:32 UTC GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000049 · wk-form4_1716496330.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,150

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000053 · wk-form4_1716496434.xml · nonDerivative · entry 1

Raskas Daniel · CIK 0001306860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,230

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:35 UTC GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000055 · wk-form4_1716496479.xml · nonDerivative · entry 1

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,230

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:33 UTC GrantCommon Stock 14,170 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000051 · wk-form4_1716496365.xml · nonDerivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000054 · wk-form4_1716496448.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,160

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:33 UTC GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000052 · wk-form4_1716496393.xml · nonDerivative · entry 1

Hulit Barbara B. · CIK 0001682154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,370

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
April 15, 2024 Filed Apr 16, 2024 20:19 UTC GrantCommon Stock 13,065 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000037 · wk-form4_1713298734.xml · nonDerivative · entry 1

Hulit Barbara B. · CIK 0001682154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,285

F1 · shares: The restricted stock units ("RSUs") were granted pursuant to a Consulting Agreement dated January 2, 2024 between Ms. Hulit and the Company. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 21:18 UTC GrantCommon Stock 11,705 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000030 · wk-form4_1710796701.xml · nonDerivative · entry 1

Hulit Barbara B. · CIK 0001682154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,220

F1 · shares: The restricted stock units ("RSUs") were granted pursuant to a Consulting Agreement dated January 2, 2024 between Ms. Hulit and the Company. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:00 UTC
Befidi RobertPresident, Diagnostics
GrantEmployee Stock Option (Right to Buy) · Derivative 21,910 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · derivative · entry 3

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,910

Underlying: Common Stock · 21,910 shares

Expires 2034-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:00 UTC
Befidi RobertPresident, Diagnostics
GrantPerformance Share Unit · Derivative 17,260 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · derivative · entry 2

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,260

Underlying: Common Stock · 17,260 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:00 UTC
Befidi RobertPresident, Diagnostics
GrantCommon Stock 9,385 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000025 · wk-form4_1709074842.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,245

F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Kaabi Faez CChief Accounting Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 20,620 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · derivative · entry 3

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,620

Underlying: Common Stock · 20,620 shares

Expires 2034-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Kaabi Faez CChief Accounting Officer
GrantCommon Stock 30,915 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · nonDerivative · entry 2

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,630

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Kaabi Faez CChief Accounting Officer
Tax withholdingCommon Stock 1,505 $22.65 $34,088.25
Disclosure

SEC source: 0001757073-24-000029 · wk-form4_1709074903.xml · nonDerivative · entry 1

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,715

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs").

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:01 UTC
Keller StephenPrincipal Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 15,460 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · derivative · entry 3

Keller Stephen · CIK 0001993880 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,460

Underlying: Common Stock · 15,460 shares

Expires 2034-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:01 UTC
Keller StephenPrincipal Financial Officer
GrantCommon Stock 11,045 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · nonDerivative · entry 2

Keller Stephen · CIK 0001993880 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,553

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:01 UTC
Keller StephenPrincipal Financial Officer
Tax withholdingCommon Stock 1,562 $22.65 $35,379.30
Disclosure

SEC source: 0001757073-24-000027 · wk-form4_1709074875.xml · nonDerivative · entry 1

Keller Stephen · CIK 0001993880 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,508

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:00 UTC
Aghdaei AmirDirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 113,370 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · derivative · entry 4

Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,370

Underlying: Common Stock · 113,370 shares

Expires 2034-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:00 UTC
Aghdaei AmirDirector · Chief Executive Officer
GrantPerformance Share Unit · Derivative 133,985 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · derivative · entry 3

Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,985

Underlying: Common Stock · 133,985 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:00 UTC
Aghdaei AmirDirector · Chief Executive Officer
GrantCommon Stock 48,570 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · nonDerivative · entry 2

Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,565

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:00 UTC
Aghdaei AmirDirector · Chief Executive Officer
Tax withholdingCommon Stock 33,367 $22.65 $755,762.55
Disclosure

SEC source: 0001757073-24-000023 · wk-form4_1709074816.xml · nonDerivative · entry 1

Aghdaei Amir · CIK 0001410055 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,995

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs").

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Nance Mark EGeneral Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 29,640 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · derivative · entry 4

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,640

Underlying: Common Stock · 29,640 shares

Expires 2034-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Nance Mark EGeneral Counsel
GrantPerformance Share Unit · Derivative 23,350 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · derivative · entry 3

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,350

Underlying: Common Stock · 23,350 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Nance Mark EGeneral Counsel
GrantCommon Stock 21,530 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · nonDerivative · entry 2

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,972

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 18:01 UTC
Nance Mark EGeneral Counsel
Tax withholdingCommon Stock 2,600 $22.65 $58,890.00
Disclosure

SEC source: 0001757073-24-000028 · wk-form4_1709074892.xml · nonDerivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,442

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2024 Filed Feb 27, 2024 23:01 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantEmployee Stock Option (Right to Buy) · Derivative 18,040 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0001757073-24-000026 · wk-form4_1709074855.xml · derivative · entry 4

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,040

Underlying: Common Stock · 18,040 shares

Expires 2034-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.